UBS ASSET MANAGEMENT AMERICAS LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,350,066
-40.6%
115,489
-15.7%
0.00%0.0%
Q2 2023$2,272,7360.0%137,0770.0%0.00%0.0%
Q1 2023$2,272,736
-3.8%
137,077
+8.0%
0.00%0.0%
Q4 2022$2,361,289
-99.8%
126,951
+4.8%
0.00%0.0%
Q3 2022$1,554,188,000
+81.8%
121,137
-0.7%
0.00%
Q2 2022$854,996,000
-18.0%
121,968
-3.0%
0.00%
Q1 2022$1,042,533,000
-6.5%
125,758
-23.6%
0.00%
Q4 2021$1,114,735,000
+52.8%
164,658
+19.6%
0.00%
Q3 2021$729,677,000
-37.3%
137,675
-32.0%
0.00%
Q2 2021$1,164,231,000
+29.5%
202,475
+3.8%
0.00%
Q1 2021$898,955,000
+38.0%
195,0010.0%0.00%
Q4 2020$651,303,000
+125.4%
195,001
+100.4%
0.00%
Q3 2020$288,984,000
-37.5%
97,301
-2.8%
0.00%
Q2 2020$462,707,000
+19.4%
100,153
-0.5%
0.00%
Q1 2020$387,476,000
+10.2%
100,643
+7.3%
0.00%
Q4 2019$351,608,000
-38.4%
93,762
-12.8%
0.00%
Q3 2019$570,936,000
+94.7%
107,521
+40.8%
0.00%
Q2 2019$293,272,00076,3730.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,517,885$22,789,0002.29%
March Altus Capital Management LP 80,890$334,0001.94%
TANAKA CAPITAL MANAGEMENT INC 111,693$462,0001.15%
PURA VIDA INVESTMENTS, LLC 395,000$1,951,0001.00%
Broadfin Capital, LLC 4,183,177$17,277,0000.93%
Catalyst Capital Advisors LLC 1,310,000$5,411,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 1,200,000$4,956,0000.48%
Baker Brothers Advisors 7,335,692$30,296,0000.27%
TURNER INVESTMENTS LLC 286,370$1,183,0000.22%
Perceptive Advisors 851,200$3,515,0000.21%
View complete list of CATALYST PHARMACEUTICALS INC shareholders